glp 1 receptor agonists for type 2 diabetes Frontiers Clinical Focus on GLP-1 Agonists
Description
These inconsistencies may be due to the small sample size of the included studies, differences in baseline characteristics of study participants, differences in study design such as follow-up duration or control group, and other factors
Pharmacological therapeutics for MAFLD To date, the currently available drugs for MAFLD treatment have been studied in many clinical trials
Focus on delaying/ preventing T1D Zealand Pharma US Inc
10.3389/fvets.2021.661546
A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)
Discrepancies were sorted by mutual agreement among authors
